Oncolytics Biotech Announces Phase 1b Study in Advanced Pancreatic Cancer is Now Active
October 20, 2015 at 06:41 AM EDT
Oncolytics Biotech Inc. (NASDAQ: ONCY) today announced that,following submission to the U.S. Food and Drug Administration ("FDA") ...
